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Abstract Human lens QC-crystallin and T5P mutant were
cloned, and their biophysical properties and thermodynamic
stability were studied. CRYGC (T5P) is one of the many Q-
crystallin mutant genes for autosomal dominant congenital
cataracts. This mutation is associated with Coppock-like
cataract, and has the phenotype of a dust-like opacity of the
fetal lens nucleus. During cloning and overexpression, the
majority of T5P mutant was found in the inclusion body. This
property is unique among the many cataract Q-crystallin mutant
genes. It is thus worthwhile to study what factors contribute to
this unique property of QC-crystallin. One possibility is changes
in conformation and stability, which can be studied using
spectroscopic measurements. In this study, conformational
change was studied by circular dichroism and fluorescence
measurements, and conformational stability was determined by
thermal unfolding probed by Trp fluorescence and time-
dependent light scattering. The T5P mutation obviously changes
conformation and decreases conformational stability. ß 2002
Federation of European Biochemical Societies. Published by
Elsevier Science B.V. All rights reserved.
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1. Introduction
Q-Crystallin, one of three major crystallins (K-, L-, and Q-
crystallin) in the mammalian lens, contains many components
(QACQF) [1]. Q-Crystallins are monomers, are synthesized in
the early stage of development, and are abundant in the nu-
cleus. The speci¢c function of Q-crystallin in the lens is not
clear, but some site-speci¢c mutations have been reported in
the many autosomal dominant congenital cataracts, in which
cataract phenotype genes were identi¢ed and missense sites
were determined. These cataract genes include CRYGC
(T5P) in Coppock-like cataract [2,3], CRYGD (R58H) in acu-
leiform cataract [3], and CRYGD (R14C) in juvenile-onset
punctate cataract [4,5]. Recent studies suggest that the R14C
QD-crystallin mutant increases phase separation temperature
[6] and that the two QD-crystallin mutant genes, R58H and
R36S, involve crystallization [7,8]. However, none of these
mutant genes has been shown to produce any signi¢cant
changes in protein conformation.
In our recent study, QC-crystallin was the most stable of the
three major crystallins (KA-, LB2-, and QC-crystallin) to un-
folding by GdnHCl but was the least stable to unfolding by
heat [9]. These di¡erences must re£ect their di¡erent confor-
mation. Unlike K-crystallin, the three-dimensional structure
has been reported for many Q-crystallins. Their structures
are characterized by two domains with paired Greek key mo-
tifs [10,11] ; the two domains are each organized around a
dyad with the connecting peptide folding back on itself to
let domains associate intramolecularly. With a known struc-
ture, the e¡ects of a mutation on QC-crystallin conformation
may be predicted and con¢rmed by spectroscopic studies. In
the present study, we chose the T5P mutant as a model for
studying such e¡ects. When the T5P mutant was cloned, the
majority of the expressed mutant was in the insoluble fraction
and was solubilized by guanidine HCl. Renatured T5P had a
conformation and stability signi¢cantly di¡erent from that of
the wild-type (WT) QC-crystallin.
2. Materials and methods
2.1. Cloning QC-crystallin and T5P mutant
Preparation of the recombinant QC-crystallin has been described
elsewhere [9]; the QC cDNA in the plasmid pDIRECT (a gift from
Dr. Mark Petrash) was subcloned into pET-20b(+) expression vector
(Novagen, Madison, WI, USA) by PCR with NdeI and HindIII. The
forward and reverse PCR primers are 5P-CGTGTCAACCCACA-
TATGGGGAAGATC-3P and 5P-TTGGTAGTGTTAAGCTTTTTT
AATACAAATCCA-3P, respectively. The corresponding forward
primer for T5P mutant is 5P-CAACCCACATATGGGGAA-
GATCCC-3P. The restriction site sequences in the above primers are
underlined. The primers were custom synthesized by Invitrogen Life
Technologies (Baltimore, MD, USA).
The nucleotide sequence of QC cDNA in the construct was deter-
mined by Sanger sequencing in an ABI Automatic Sequencing System
(Perkin-Elmer Applied Biosystems, Foster City, CA, USA) at Brig-
ham and Women’s Hospital Automatic Sequencing and Genotyping
Facilities [12].
For overexpression, Escherichia coli BL21(DE3) was transformed
with the expression constructs pET-QC and pET-T5P. The details for
gene expression and protein puri¢cation have been described previ-
ously [9,12]. Although the WT QC-crystallin was expressed exclusively
in the soluble fraction, the majority of T5P was in the insoluble
fraction, as detected by Western blot with polyclonal antibodies spe-
ci¢c to Q-crystallin. The insoluble T5P mutant was solubilized by 4 M
GdnHCl. Upon dialysis, some of the T5P mutant became soluble. The
solubility was checked with cell lysate solubilized with Triton-100 in
increasing concentrations, and the amount of soluble T5P mutant was
estimated with SDS^PAGE. The purity of the proteins was con¢rmed
with SDS^PAGE, and the size was determined by FPLC gel ¢ltration.
For comparison, the WT QC-crystallin was treated similarly with
GdnHCl and renatured; the sample is referred to as denatured-rena-
tured WT QC-crystallin (DR-WT).
SDS^PAGE was performed in a slab gel (15% acrylamide) under
reducing conditions according to the method of Laemmli [13]. West-
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ern blotting was performed with polyclonal anti-Q-crystallin antibodies
(a gift from Dr. Samuel Zigler and Dr. Usha Andley). Protein con-
centrations were determined by measuring absorption at 280 nm:
A0:1% = 2.14 for both WT and T5P QC-crystallins [14].
2.2. Spectroscopic measurements
CD spectra were obtained with an Aviv Circular Dichroism spec-
trometer (model 60 DS, Aviv Associates, Lakewood, NJ, USA). Five
scans were recorded and averaged and followed by a polynomial ¢t-
ting program. The CD is expressed as deg cm2 dmol31.
Fluorescence was measured with a Shimadzu spectro£uorometer
(model RF-5301PC, Shimadzu Instruments, Columbia, MD, USA).
Trp emission was scanned with an excitation wavelength at 295 nm.
2.3. Thermal stability measurements
Thermal stability was studied by temperature-dependent changes of
Trp emission intensity and wavelength [9] and time-dependent light
scattering at 62‡C. In the temperature-dependent study, Trp £uores-
cence was measured at 5‡C intervals between 25‡C and 65‡C. A 15
min equilibrium time was allowed for each temperature. Temperature
was controlled with a Lauda RC-6 water bath (Brinkmann Instru-
ments, Westbury, NY, USA).
For the time-dependent scattering measurements, the £uorometer
was set at 400 nm for both excitation and emission wavelength and at
65‡C [15]. Initially, the WT QC-crystallin samples with increasing con-
centrations were measured to determine the optimal conditions. Three
samples of WT, DR-WT, and T5P mutant were then measured under
the same conditions.
3. Results
3.1. Recombinant QC-crystallin and T5P mutant
SDS^PAGE and Western blots show a 21-kDa band for
both WT and T5P QC-crystallins (Fig. 1). FPLC gel ¢ltration
indicated that QC-crystallin was a monomer of 21 kDa [8], and
mutation did not change the size of the monomer as deter-
mined by FPLC (data not shown). Solubility measurements
indicated that the T5P mutant was not soluble beyond 0.4 mg/
ml.
3.2. Spectroscopic study
Trp £uorescence displayed an emission maximum at 329^
330 nm for the WT, DR-WT, and T5P mutant QC-crystallins
(Fig. 2), indicating that Trp residues were buried relative to
those in recombinant KA- or KB-crystallin (Vem = 335^337
nm). Mutation decreased the emission intensity by almost
one-third but shifted the emission maximum only 1^2 nm to
longer wavelength.
The far-UV CD spectra displayed a trough at 215^218 nm,
a characteristic of L-pleated sheet conformation (Fig. 3A).
The trough decreased signi¢cantly for the mutant, indicating
a decrease in the L-pleated sheet conformation. With the pro-
gram PROSEC [16], the calculated content of K-helix, L-sheet,
L-turn and random coil were 8, 51, 15, and 27%, respectively,
for the T5P mutant and 8, 72, 2, and 19%, respectively, for the
WT. Decreased L-sheet conformation and increased random
coil were obvious for the T5P mutant.
The near-UV CD re£ects the tertiary structure (Fig. 3B). A
Fig. 1. SDS^PAGE (A) and Western blots (B) of human lens re-
combinant T5P mutant. A: Lane 1, markers; lane 2, WT; lane 3,
puri¢ed T5P; lane 4, expression lysate supernatant; lane 5, lysate
pellet; and lane 6, total lysate. B: Lane 1, WT; and lane 2, puri¢ed
T5P.
Fig. 2. Trp £uorescence spectra of QC-crystallin samples. Protein
concentrations were 0.08 mg/ml in 50 mM phosphate bu¡er, pH
7.4. Curve 1, WT; curve 2, DR-WT; and curve 3, T5P.
Fig. 3. Far-UV (A) and near-UV CD (B) of QC-crystallin samples.
Protein concentrations were 0.2 mg/ml in 50 mM phosphate bu¡er,
pH 7.4. Cell path lengths were 10 mm and 1 mm for the measure-
ments at near- and far-UV regions, respectively. Curve 1, WT;
curve 2, DR-WT; and curve 3, T5P.
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decreased intensity and loss of vibronic structure for the T5P
mutant were observed.
3.3. Thermal unfolding studies
The Trp emission intensity and maximum are shown as a
function of temperature for the WT, DR-WT, and T5P mu-
tant QC-crystallins in Fig. 4. As observed previously [9], Trp
emission intensity for QC-crystallin decreases linearly with in-
creasing temperatures, but the emission maximal wavelengths
do not change; at around 60‡C, both changes abruptly for the
T5P mutant, but no appreciable changes were observed for
either WT or DR-WT. The results indicated that T5P muta-
tion decreased the thermal stability of QC-crystallin.
Time-course scattering measurements for unfolding and ag-
gregation showed that the T5P mutant unfolded and aggre-
gated dramatically under the conditions in which neither WT
nor DR-WT showed much scattering (Fig. 5).
4. Discussion
It is interesting to observe that the T5P mutation makes QC-
crystallin insoluble in overexpression; this must be related to
structural change. From the amino acid sequence and the
secondary structure predicted by PHD Protein Prediction pro-
gram [17], there were 16 L-strands (L1^L16) in QC-crystallin.
The Thr-5 residue located in the L1-strand and replacement
with Pro likely caused the disruption of this L-strand, since
proline is known to be a strong breaker of L-strands [18,19].
Our present far-UV CD data strongly suggested a decrease in
L-pleated sheet conformation for the T5P mutant. This phe-
nomenon had been observed in amyloid peptide [20], in which
a replacement of a residue in sequence between 12 and 26
residues with Pro results in a complete loss in the capability
of peptide to form ¢brils.
Spectroscopic measurements indicated changes of both sec-
ondary and tertiary structures for the T5P mutant. Both Trp
£uorescence and near-UV CD detect the local structural
change of the aromatic acid residues but the near-UV CD is
usually more sensitive to changes in the overall protein terti-
ary structure. This is because of the cooperative nature of
protein conformation. Thus we observed little change in sol-
vent accessibility and Trp £uorescence maximum wavelength
but a wide-spread change in near-UV CD. Overall, these ob-
served changes indicated that the T5P mutant had a relatively
loose structure or was partially unfolded, which made protein
susceptible to aggregation and insolubilization, possibly
through increased hydrophobic interactions.
The structure of Q-crystallin can be further visualized with
the crystallographic data [10,21,22]; it is characterized by the
presence of four Greek key motifs: motifs 1 and 2 in the N-
terminal domain and motifs 3 and 4 in the C-terminal do-
main. Each motif consists of four antiparallel L-strands and
four motifs form four L-sheets. Two of four L-sheets (L1-sheet
and L3-sheet) lie on the outside of the molecule and the other
two (L2-sheet and L4-sheet) are in partial contact (domain
association). It is obvious from the Rasmol graphic model
using crystallographic coordinates of QB-crystallin [22] that
the L1-strand is not on the surface of intradomain association.
The Thr-5 residue is in the L1-strand and L1-sheet; T5P mu-
tation destroys the L1-strand and thus likely also destroys the
L1-sheet, which in turn demolishes the highly symmetrical
structure of Q-crystallin. This change of tertiary structure is
re£ected in a change in the near-UV CD (Fig. 3B). It is to be
noted that the a¡ected amino acid, Thr-5, is invariant among
various human Q-crystallins (QA-, QB-, QC-, and QD-crystallin)
as well as among species of human, bovine, rat, and mouse.
Another possible e¡ect of the T5P mutation is the distur-
bance in protein^protein interactions between QC-crystallin
and other crystallins. Our recent study in the mammalian
two-hybrid system assays indicates that there are interactions
between KA- and QC-crystallin as well as between LB2- and
QC-crystallin [23]. These interactions were detected inside the
cells and are physiologically relevant; they may be responsible
for the solubility of lens crystallins and lens transparency. We
plan to subclone many cataract mutant genes, including T5P
QC-crystallin, into the two-hybrid vectors and to assay the
Fig. 5. Time-course scattering intensities of QC-crystallin samples at
65‡C. Protein concentrations were 0.05 mg/ml in 50 mM phosphate
bu¡er, pH 7.6. Curve 1, WT; curve 2, DR-WT; and curve 3, T5P.
Fig. 4. Thermal unfolding curves of QC-crystallin samples measured
by Trp £uorescence intensity (A) and emission maximum (B). Pro-
tein concentrations were 0.08 mg/ml in 50 mM phosphate bu¡er,
pH 7.6. Curve 1, WT; curve 2, DR-WT; and curve 3, T5P.
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e¡ects of mutation on the protein^protein interactions. It is
possible that decrease or loss of protein^protein interaction
will be observed for the mutants. For example, the imperfect
folding of the T5P mutant may cause a decrease or even loss
of the ability to interact with other crystallins.
The T5P mutant is one of the cataract genes that provide a
clear relationship between the cataract genotype and the cor-
responding phenotype. The loss of stability to heat and of
solubility of the T5P mutant must be caused by the conforma-
tional change, an observation distinctly di¡erent from that for
the human cataract QD-crystallin mutant genes, R14C and
R58H, which show no conformational change and destabili-
zation [6,8]. These observations may arise from the fact that
R14 and R58 residues are not in the sequences favoring for-
mation of L-strands. Our results suggest that conformational
change and destabilization of lens crystallins depend on the
sites of mutation; they may be two events in the cascade of
cataract formation [1]. In other cataract crystallin mutant
genes, R120G of KB-crystallin and R116C of KA-crystallin,
both R120 and R116 are in the sequences of L-strands as
predicted by PHD program and these mutants were reported
to cause conformational change and aggregation [24,25].
In conclusion, our studies indicated that the T5P QC-crys-
tallin mutant has undergone a conformational change and
destabilization. We believe that the events observed here are
not only the cause of the Coppock-like cataract but also are a
general mechanism for inherited cataracts.
Acknowledgements: This work was supported by grants from the Na-
tional Institutes of Health (EY05803) and Massachusetts Lions Eye
Research Fund.
References
[1] Harding, J. (1991) in: Cataract: Biochemistry, Epidemiology
and Pharmacology, Ch. 5, pp. 195^217, Chapman and Hall,
London.
[2] Lubsen, N.H., Renwick, J.H., Tsui, L.C., Breitman, M.L. and
Schoenmakers, J.G. (1987) Proc. Natl. Acad. Sci. USA 84, 489^
492.
[3] Heon, E., Priston, M., Schorderet, D.F., Billingsley, G.D., Gir-
ard, P.O., Lubsen, N. and Munier, F.L. (1999) Am. J. Hum.
Genet. 65, 1261^1267.
[4] Stephan, D.A., Gillanders, E., Vanderveen, D., Freas-Lutz, D.,
Wistow, G., Baxevanis, A.D., Robbins, C.M., VanAuken, A.,
Quesenberry, M.I., Bailey-Wilson, J., Juo, S.H., Trent, J.M.,
Smith, L. and Brownstein, M.J. (1999) Proc. Natl. Acad. Sci.
USA 96, 1008^1012.
[5] Smith, R.S., Hawes, N.L., Chang, B., Roderick, T.H., Akeson,
E.C., Heckenlively, J.R., Gong, X., Wang, X. and Davisson,
M.T. (2000) Genomics 63, 314^320.
[6] Pande, A., Pande, J., Asherie, N., Lomakin, A., Ogun, O., King,
J.A., Lubsen, N.H., Walton, D. and Benedek, G.B. (2000) Proc.
Natl. Acad. Sci. USA 97, 1993^1998.
[7] Kmoch, S., Brynda, J., Asfaw, B., Bezouska, K., Novak, P.,
Rezacova, P., Ondrova, L., Filipec, M., Sedlacek, J. and Elleder,
M. (2000) Hum. Mol. Genet. 9, 1779^1786.
[8] Pande, A., Pande, J., Asherie, N., Lomakin, A., Ogun, O., King,
J. and Benedek, G.B. (2001) Proc. Natl. Acad. Sci. USA 98,
6116^6120.
[9] Fu, L. and Liang, J.J.N. (2001) Mol. Vis. 7, 178^182.
[10] Blundell, T., Lindley, P., Miller, L., Moss, D., Slingsby, C.,
Tickle, I., Turnell, B. and Wistow, G. (1981) Nature 289, 771^777.
[11] White, H.E., Driessen, H.P., Slingsby, C., Moss, D.S. and Lind-
ley, P.F. (1989) J. Mol. Biol. 207, 217^235.
[12] Sun, T.-X., Das, B.K. and Liang, J.J.N. (1997) J. Biol. Chem.
272, 6220^6225.
[13] Laemmli, U.K. (1970) Nature 227, 680^685.
[14] Mach, H., Middaugh, C.R. and Lewis, R.V. (1992) Anal. Bio-
chem. 200, 74^80.
[15] Sun, T.-X. and Liang, J.J.N. (1998) J. Biol. Chem. 273, 286^290.
[16] Yang, J.T., Wu, C.S. and Martinez, H.M. (1986) Methods Enzy-
mol. 130, 208^269.
[17] Rost, B. (1996) Methods Enzymol. 266, 525^539.
[18] Chou, P.Y. and Fasman, G.D. (1978) Annu. Rev. Biochem. 47,
251^276.
[19] Chou, P.Y. (1989) in: Prediction of Protein Structures and the
Principles of Protein Conformation (Fasman, G.D., Ed.), pp.
549^586, Plenum Press, New York.
[20] Wood, S.J., Wetzel, R., Martin, J.D and Hurle, M.R. (1995)
Biochemistry 34, 724^730.
[21] Najmudin, S., Nalini, V., Driessen, H.P.C., Slingsby, C., Blun-
dell, T.L., Moss, D.S. and Lindley, P.F. (1993) Acta Crystallogr.
49, 223.
[22] Lindley, P.F., Narebor, M.E., Summers, L.J. and Wistow, G.J.
(1985) in: The Ocular Lens: Structure, Function, and Pathology
(Maisel, H., Ed.), pp. 123^167, Marcel Dekker, New York.
[23] Fu, L. and Liang, J.J.N. (2002) J. Biol. Chem. 277, 4255^4260.
[24] Bova, M.P., Yaron, O., Huang, Q., Ding, L., Haley, D.A., Stew-
art, P.L. and Horwitz, J. (1999) Proc. Natl. Acad. Sci. USA 96,
6137^6142.
[25] Cobb, B.A. and Petrash, J.M. (2000) Biochemistry 39, 15791^
15798.
FEBS 25801 11-3-02
L. Fu, J.J.-N. Liang/FEBS Letters 513 (2002) 213^216216
